Lion Street Advisors, LLC Cardiol Therapeutics Inc. Transaction History
Lion Street Advisors, LLC
- $307 Million
- Q4 2024
A detailed history of Lion Street Advisors, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Lion Street Advisors, LLC holds 307,666 shares of CRDL stock, worth $406,119. This represents 0.13% of its overall portfolio holdings.
Number of Shares
307,666
Previous 273,281
12.58%
Holding current value
$406,119
Previous $541,000
26.8%
% of portfolio
0.13%
Previous 0.19%
Shares
4 transactions
Others Institutions Holding CRDL
# of Institutions
44Shares Held
4.94MCall Options Held
5.2KPut Options Held
9.5K-
Tejara Capital LTD London, X01.77MShares$2.34 Million1.67% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.17MShares$1.55 Million0.46% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$1.05 Million0.36% of portfolio
-
Mgo One Seven LLC Beachwood, OH100KShares$132,0000.01% of portfolio
-
Knoll Capital Management, LLC Miami, FL100KShares$132,0000.1% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $81.8M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...